ARDS / hypoxemic pneumonia Phase 2 trial initiation 1H 2026; early data by year end; market opportunity of ~200,000–300,000 patients annually in ...
Synthetic pyrethroids, as shown in a literature review of scientific research, can cause adverse cardiovascular effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results